Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Clinical trial NCT03464136 · COMPLETED
Trial details
- NCT number
- NCT03464136
- Sponsor
- Janssen Scientific Affairs, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-29
- Primary completion
- 2020-12-15
- Enrollment
- 386
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.